Diagnostic Product Developer
Jiemian News learned that on September 3, Illumina, Inc. announced the launch of Illumina Protein Prep. This testing product will help researchers incorporate proteomic analysis into large-scale genomic studies to support scientific discovery and clinical research. According to the company's press release, Illumina Protein Prep, powered by SOMAmer™ technology, can detect 9,500 unique human protein targets, making it the testing product with the widest coverage based on NGS (next-generation sequencing) readouts currently available. In June this year, Illumina announced the acquisition of SomaLogic, a company in the field of data-driven proteomics technology. (Jiemian News reporter Chen Yang)